Editor's Choice Nanotechnology based blood test to predict aggressive prostate cancer accurately June 13, 2017 A new diagnostic developed by Alberta scientists will allow men to bypass painful biopsies to…
Editor's Choice ASCO 2017: Healthy Lifestyle After Colon Cancer Diagnosis Helps Patients Live Longer June 13, 2017 A study of 992 patients with stage III colon cancer found that those who reported…
Prostate Cancer Australian experts concerned men with prostate cancer not informed of all treatment options June 13, 2017 Cancer experts and patient advocacy groups are using Men’s Health Week 2017 (12-18 June) to highlight…
Editor's Choice Five years before brain cancer diagnosis, changes detectable in blood June 11, 2017 Changes in immune activity appear to signal a growing brain tumour five years before symptoms…
Editor's Choice New practice-changing research will reduce the need for major surgery in many melanoma patients June 10, 2017 New findings from a large international clinical trial published in the New England Journal of Medicine…
Editor's Choice ASCO 2017: Higher gut bacteria diversity tied to slower metastatic melanoma progression June 9, 2017 The blend of bacteria in the digestive tract of metastatic melanoma patients is associated with…
Breast Cancer Balance, gait negatively impacted after chemotherapy treatment June 9, 2017 A single chemotherapy treatment can result in a significant negative impact on walking gait and…
Editor's Choice ASCO 2017: Two combination therapies shrink melanoma brain metastases in more than half of patients June 8, 2017 High response rates to a pair of combination therapies point to potentially new options for…
Breast Cancer ASCO 2017: Behavioural therapy lowers survivors’ fear of cancer recurrence June 5, 2017 About 50% of all cancer survivors and 70% of young breast cancer survivors report moderate…
Cancer Drug News ASCO 2017: New Drug Shows Durable Efficacy Across Diverse Pediatric and Adult Cancers June 5, 2017 Scientists may have developed the first targeted, oral, tumour-type agnostic therapy – a cancer medicine…